This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Institute of Health and Medical Research. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Mathilde Girard: Innovator in Eukaryotic Cell Reprogramming
Introduction
Mathilde Girard is a prominent inventor based in Evry, France. She has made significant contributions to the field of cellular biology, particularly in the area of eukaryotic cell reprogramming. Her innovative work has the potential to advance medical research and therapeutic applications.
Latest Patents
Mathilde Girard holds a patent for her invention titled "Reprogrammation of eukaryotic cells with engineered microvesicles." This invention relates to a non-genetic, detergent-free, bacteria-free method for reprogramming eukaryotic cells, specifically for obtaining induced pluripotent stem cells (iPS). The method utilizes engineered microvesicles that carry at least one reprogramming transcription factor, ensuring that these microvesicles are virus-free. This groundbreaking approach opens new avenues for stem cell research and regenerative medicine.
Career Highlights
Girard is affiliated with the National Institute of Health and Medical Research, where she continues to explore innovative solutions in her field. Her dedication to research and development has positioned her as a key figure in advancing our understanding of cellular reprogramming.
Collaborations
Mathilde has collaborated with notable colleagues, including Philippe Mangeot and Marc Peschanski. These partnerships have fostered a collaborative environment that enhances the impact of her research.
Conclusion
Mathilde Girard's contributions to the field of eukaryotic cell reprogramming exemplify her innovative spirit and commitment to scientific advancement. Her work not only enriches the scientific community but also holds promise for future medical breakthroughs.